Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > F5(Gene name) > Human
  • Add your favorite
  • F5 (Gene name),
  • Coagulation factor V (Protein name ),  FA5_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    F5;
    Protein name:
    Coagulation factor V;
    Alternative:
    Proaccelerin, labile factor;Activated protein C cofactor;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Factor Va, the activated form of factor V, is composed of a heavy chain and a light chain, non-covalently bound. The interaction between the two chains is calcium-dependent.
    Function:
    Central regulator of hemostasis. It serves as a critical cofactor for the prothrombinase activity of factor Xa that results in the activation of prothrombin to thrombin.
    Subcellular Location:
    Secreted
    Protein Attributes:
    Sequence length:
    2224
    Sequence:
    50:
    MFPGCPRLWV | LVVLGTSWVG | WGSQGTEAAQ | LRQFYVAAQG | ISWSYRPEPT | 
    100:
    NSSLNLSVTS | FKKIVYREYE | PYFKKEKPQS | TISGLLGPTL | YAEVGDIIKV | 
    150:
    HFKNKADKPL | SIHPQGIRYS | KLSEGASYLD | HTFPAEKMDD | AVAPGREYTY | 
    200:
    EWSISEDSGP | THDDPPCLTH | IYYSHENLIE | DFNSGLIGPL | LICKKGTLTE | 
    250:
    GGTQKTFDKQ | IVLLFAVFDE | SKSWSQSSSL | MYTVNGYVNG | TMPDITVCAH | 
    300:
    DHISWHLLGM | SSGPELFSIH | FNGQVLEQNH | HKVSAITLVS | ATSTTANMTV | 
    350:
    GPEGKWIISS | LTPKHLQAGM | QAYIDIKNCP | KKTRNLKKIT | REQRRHMKRW | 
    400:
    EYFIAAEEVI | WDYAPVIPAN | MDKKYRSQHL | DNFSNQIGKH | YKKVMYTQYE | 
    450:
    DESFTKHTVN | PNMKEDGILG | PIIRAQVRDT | LKIVFKNMAS | RPYSIYPHGV | 
    500:
    TFSPYEDEVN | SSFTSGRNNT | MIRAVQPGET | YTYKWNILEF | DEPTENDAQC | 
    550:
    LTRPYYSDVD | IMRDIASGLI | GLLLICKSRS | LDRRGIQRAA | DIEQQAVFAV | 
    600:
    FDENKSWYLE | DNINKFCENP | DEVKRDDPKF | YESNIMSTIN | GYVPESITTL | 
    650:
    GFCFDDTVQW | HFCSVGTQNE | ILTIHFTGHS | FIYGKRHEDT | LTLFPMRGES | 
    700:
    VTVTMDNVGT | WMLTSMNSSP | RSKKLRLKFR | DVKCIPDDDE | DSYEIFEPPE | 
    750:
    STVMATRKMH | DRLEPEDEES | DADYDYQNRL | AAALGIRSFR | NSSLNQEEEE | 
    800:
    FNLTALALEN | GTEFVSSNTD | IIVGSNYSSP | SNISKFTVNN | LAEPQKAPSH | 
    850:
    QQATTAGSPL | RHLIGKNSVL | NSSTAEHSSP | YSEDPIEDPL | QPDVTGIRLL | 
    900:
    SLGAGEFKSQ | EHAKHKGPKV | ERDQAAKHRF | SWMKLLAHKV | GRHLSQDTGS | 
    950:
    PSGMRPWEDL | PSQDTGSPSR | MRPWKDPPSD | LLLLKQSNSS | KILVGRWHLA | 
    1000:
    SEKGSYEIIQ | DTDEDTAVNN | WLISPQNASR | AWGESTPLAN | KPGKQSGHPK | 
    1050:
    FPRVRHKSLQ | VRQDGGKSRL | KKSQFLIKTR | KKKKEKHTHH | APLSPRTFHP | 
    1100:
    LRSEAYNTFS | ERRLKHSLVL | HKSNETSLPT | DLNQTLPSMD | FGWIASLPDH | 
    1150:
    NQNSSNDTGQ | ASCPPGLYQT | VPPEEHYQTF | PIQDPDQMHS | TSDPSHRSSS | 
    1200:
    PELSEMLEYD | RSHKSFPTDI | SQMSPSSEHE | VWQTVISPDL | SQVTLSPELS | 
    1250:
    QTNLSPDLSH | TTLSPELIQR | NLSPALGQMP | ISPDLSHTTL | SPDLSHTTLS | 
    1300:
    LDLSQTNLSP | ELSQTNLSPA | LGQMPLSPDL | SHTTLSLDFS | QTNLSPELSH | 
    1350:
    MTLSPELSQT | NLSPALGQMP | ISPDLSHTTL | SLDFSQTNLS | PELSQTNLSP | 
    1400:
    ALGQMPLSPD | PSHTTLSLDL | SQTNLSPELS | QTNLSPDLSE | MPLFADLSQI | 
    1450:
    PLTPDLDQMT | LSPDLGETDL | SPNFGQMSLS | PDLSQVTLSP | DISDTTLLPD | 
    1500:
    LSQISPPPDL | DQIFYPSESS | QSLLLQEFNE | SFPYPDLGQM | PSPSSPTLND | 
    1550:
    TFLSKEFNPL | VIVGLSKDGT | DYIEIIPKEE | VQSSEDDYAE | IDYVPYDDPY | 
    1600:
    KTDVRTNINS | SRDPDNIAAW | YLRSNNGNRR | NYYIAAEEIS | WDYSEFVQRE | 
    1650:
    TDIEDSDDIP | EDTTYKKVVF | RKYLDSTFTK | RDPRGEYEEH | LGILGPIIRA | 
    1700:
    EVDDVIQVRF | KNLASRPYSL | HAHGLSYEKS | SEGKTYEDDS | PEWFKEDNAV | 
    1750:
    QPNSSYTYVW | HATERSGPES | PGSACRAWAY | YSAVNPEKDI | HSGLIGPLLI | 
    1800:
    CQKGILHKDS | NMPMDMREFV | LLFMTFDEKK | SWYYEKKSRS | SWRLTSSEMK | 
    1850:
    KSHEFHAING | MIYSLPGLKM | YEQEWVRLHL | LNIGGSQDIH | VVHFHGQTLL | 
    1900:
    ENGNKQHQLG | VWPLLPGSFK | TLEMKASKPG | WWLLNTEVGE | NQRAGMQTPF | 
    1950:
    LIMDRDCRMP | MGLSTGIISD | SQIKASEFLG | YWEPRLARLN | NGGSYNAWSV | 
    2000:
    EKLAAEFASK | PWIQVDMQKE | VIITGIQTQG | AKHYLKSCYT | TEFYVAYSSN | 
    2050:
    QINWQIFKGN | STRNVMYFNG | NSDASTIKEN | QFDPPIVARY | IRISPTRAYN | 
    2100:
    RPTLRLELQG | CEVNGCSTPL | GMENGKIENK | QITASSFKKS | WWGDYWEPFR | 
    2150:
    ARLNAQGRVN | AWQAKANNNK | QWLEIDLLKI | KKITAIITQG | CKSLSSEMYV | 
    2200:
    KSYTIHYSEQ | GVEWKPYRLK | SSMVDKIFEG | NTNTKGHVKN | FFNPPIISRF | 
    2224:
    IRVIPKTWNQ | SIALRLELFG | CDIY
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    UniGene:
    Pfam:
    KEGG:
    String:
    SMR:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human Coagulation factor V
    Cat.:
    E0728p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Coagulation factor V
    Cat.:
    E0728h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Coagulation factor V
    Cat.:
    E0728b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Coagulation factor V
    Cat.:
    E0728m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Coagulation factor V
    Cat.:
    U0728p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Coagulation factor V
    Cat.:
    U0728b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Coagulation factor V
    Cat.:
    U0728h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Coagulation factor V
    Cat.:
    U0728m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Coagulation factor V
    Polyclonal Antibody for Human Coagulation factor V
    Polyclonal Antibody for Human Coagulation factor V
    Cat.:
    P0728Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Coagulation factor V
    Cat.:
    P0728Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Coagulation factor V
    Monoclonal Antibody for Human Coagulation factor V
    Monoclonal Antibody for Human Coagulation factor V
    Monoclonal Antibody for Human Coagulation factor V
    Protein for Human Coagulation factor V
    Protein for Human Coagulation factor V
    Protein for Human Coagulation factor V
    Protein for Human Coagulation factor V

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANTS ARG-858; ARG-865; GLU-925; PHE-1397 AND VAL-1764
    2. 2.
      "Structure of the gene for human coagulation factor V."
      Cripe L.D. , Moore K.D. , Kane W.H.
      Biochemistry31:3777-3785(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    3. 3.
      SeattleSNPs variation discovery resource
      Submitted (2003-08) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT LEIDEN GLN-534;VARIANTS SER-15; HIS-107; THR-413; LYS-513; SER-809; THR-817; ARG-858; ARG-865; SER-915; GLU-925; SER-969; LEU-980; GLN-1146; ILE-1285; SER-1404; ALA-1530 AND THR-2148
    4. 4.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA];VARIANT LEIDEN GLN-534
    5. 5.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1030;VARIANT LYS-513
      tissue: Placenta.
    6. 6.
      "Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats."
      Kane W.H. , Ichinose A. , Hagen F.S. , Davie E.W.
      Biochemistry26:6508-6514(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-1600;VARIANTS ARG-858; ARG-865; GLU-925 AND ILE-1285
    7. 7.
      "Human coagulation factor V, exon 13, missense mutation Asn713Ser."
      Kostka H.
      Submitted (2006-01) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 658-1598
    8. 8.
      "Studies on hereditary deficiency of coagulation factor V."
      Xie F. , Cheng F. , Zhu X.
      Zhonghua Xue Ye Xue Za Zhi22:453-456(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 660-1598;VARIANTS ARG-858; ARG-865; GLU-925 AND PHE-1397
    9. 9.
      "Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin."
      Kane W.H. , Davie E.W.
      Proc. Natl. Acad. Sci. U.S.A.83:6800-6804(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1188-1215 AND 1315-2224
    10. 10.
      "The serine protease cofactor factor V is synthesized by lymphocytes."
      Shen N.L.L. , Fan S.-T. , Pyati J. , Graff R. , Lapolla R.J. , Edgington T.S.
      J. Immunol.150:2992-3001(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA]
      tissue: Fibroblast.
    11. 11.
      "Mechanism of inhibition of activated protein C by protein C inhibitor."
      Suzuki K. , Nishioka J. , Kusumoto H. , Hashimoto S.
      J. Biochem.95:187-195(1984) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;HETERODIMER WITH SERPINA5
    12. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: COPPER-BINDING
    13. 13.
      "Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor."
      Meijers J.C. , Kanters D.H. , Vlooswijk R.A. , van Erp H.E. , Hessing M. , Bouma B.N.
      Biochemistry27:4231-4237(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;HETERODIMER WITH SERPINA5
    14. 14.
      "Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity."
      Pittman D.D. , Tomkinson K.N. , Michnick D. , Selighsohn U. , Kaufman R.J.
      Biochemistry33:6952-6959(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SULFATION
    15. 15.
      "Sulfation of tyrosine residues in coagulation factor V."
      Hortin G.L.
      Blood76:946-952(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SULFATION
    16. 16.
      "The mechanism of inactivation of human factor V and human factor Va by activated protein C."
      Kalafatis M. , Rand M.D. , Mann K.G.
      J. Biol. Chem.269:31869-31880(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CLEAVAGE AT ARG-334; ARG-534; ARG-707 AND LYS-1022 BY ACTIVATED PROTEIN C
    17. 17.
      "Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor."
      Kise H. , Nishioka J. , Kawamura J. , Suzuki K.
      Eur. J. Biochem.238:88-96(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: HETERODIMER WITH SERPINA5
    18. 18.
      "Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles."
      Nishioka J. , Ning M. , Hayashi T. , Suzuki K.
      J. Biol. Chem.273:11281-11287(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;HETERODIMER WITH SERPINA5
    19. 19.
      "Mutations in coagulation factors in women with unexplained late fetal loss."
      Martinelli I. , Taioli E. , Cetin I. , Marinoni A. , Gerosa S. , Villa M.V. , Bozzo M. , Mannucci P.M.
      N. Engl. J. Med.343:1015-1018(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN RPRGL1 SUSCEPTIBILITY
    20. 20.
      "Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions."
      Hayashi T. , Nishioka J. , Kamada H. , Asanuma K. , Kondo H. , Gabazza E.C. , Ido M. , Suzuki K.
      J. Thromb. Haemost.2:949-961(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;HETERODIMER WITH SERPINA5
    21. 21.
      "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
      Liu T. , Qian W.-J. , Gritsenko M.A. , Camp D.G. II , Monroe M.E. , Moore R.J. , Smith R.D.
      J. Proteome Res.4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-460; ASN-821; ASN-977 AND ASN-1559
      tissue: Plasma.
    22. 22.
      "Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach."
      Lewandrowski U. , Moebius J. , Walter U. , Sickmann A.
      Mol. Cell. Proteomics5:226-233(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297
      tissue: Platelet.
    23. 23.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Platelet.
    24. 24.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-640;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    25. 25.
      "Crystal structures of the membrane-binding C2 domain of human coagulation factor V."
      Macedo-Ribeiro S. , Bode W. , Huber R. , Quinn-Allen M.A. , Kim S.W. , Ortel T.L. , Bourenkov G.P. , Bartunik H.D. , Stubbs M.T. , Kane W.H. , Fuentes-Prior P.
      Nature402:434-439(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2065-2224
    26. 26.
      "A polymorphism in the human coagulation factor V gene."
      Bayston T.A. , Ireland H. , Olds R.J. , Thein S.L. , Lane D.A.
      Hum. Mol. Genet.3:2085-2085(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VAL-1764
    27. 27.
      "Mutation in blood coagulation factor V associated with resistance to activated protein C."
      Bertina R.M. , Koeleman B.P.C. , Koster T. , Rosendaal F.R. , Dirven R.J. , de Ronde H. , van der Velden P.A. , Reitsma P.H.
      Nature369:64-67(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT LEIDEN GLN-534
    28. 28.
      "Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma."
      Lunghi B. , Iacoviello L. , Gemmati D. , Dilasio M.G. , Castoldi E. , Pinotti M. , Castaman G. , Redaelli R. , Mariani G. , Marchetti G. , Bernardi F.
      Thromb. Haemost.75:45-48(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS ILE-1285 AND ARG-1327
    29. 29.
      "Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis."
      Mahmoud A.E.A. , Elias E. , Beauchamp N. , Wilde J.T.
      Gut40:798-800(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ASSOCIATION OF VARIANT LEIDEN GLN-534 WITH SUSCEPTIBILITY TO BUDD-CHIARI SYNDROME
    30. 30.
      "A novel mutation of Arg306 of factor V gene in Hong Kong Chinese."
      Chan W.P. , Lee C.K. , Kwong Y.L. , Lam C.K. , Liang R.
      Blood91:1135-1139(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HONG KONG GLY-334;VARIANT LYS-513
    31. 31.
      "Factor V Cambridge: a new mutation (Arg306-to-Thr) associated with resistance to activated protein C."
      Williamson D. , Brown K. , Luddington R. , Baglin C. , Baglin T.
      Blood91:1140-1144(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT THPH2 THR-334
    32. 32.
      "Clinical significance of Arg306 mutations of factor V gene."
      Liang R. , Lee C.K. , Wat M.S. , Kwong Y.L. , Lam C.K. , Liu H.W.
      Blood92:2599-2600(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HONG KONG GLY-334
    33. 33.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT LEIDEN GLN-534;VARIANTS HIS-107; THR-413; LYS-513; SER-809; THR-817; ARG-858; ARG-865; GLU-925; GLN-1146; ALA-1530; SER-1685; VAL-1749; VAL-1764; ILE-1820 AND GLY-2222
    34. 34.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    35. 35.
      "Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family."
      Castoldi E. , Simioni P. , Kalafatis M. , Lunghi B. , Tormene D. , Girelli D. , Girolami A. , Bernardi F.
      Blood96:1443-1448(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT FA5D CYS-1730;VARIANT LEIDEN GLN-534;VARIANT ARG-1327
    36. 36.
      "Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency."
      van Wijk R. , Nieuwenhuis K. , van den Berg M. , Huizinga E.G. , van der Meijden B.B. , Kraaijenhagen R.J. , van Solinge W.W.
      Blood98:358-367(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS THPH2 ARG-613 AND CYS-1730
    37. 37.
      "Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding."
      Schrijver I. , Houissa-Kastally R. , Jones C.D. , Garcia K.C. , Zehnder J.L.
      Thromb. Haemost.87:294-299(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT THPH2 HIS-2102
    38. 38.
      "Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein."
      Duga S. , Montefusco M.C. , Asselta R. , Malcovati M. , Peyvandi F. , Santagostino E. , Mannucci P.M. , Tenchini M.L.
      Blood101:173-177(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT FA5D CYS-2102;CHARACTERIZATION OF VARIANT FA5D CYS-2102
    39. 39.
      "Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C."
      Mumford A.D. , McVey J.H. , Morse C.V. , Gomez K. , Steen M. , Norstrom E.A. , Tuddenham E.G.D. , Dahlback B. , Bolton-Maggs P.H.B.
      Br. J. Haematol.123:496-501(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT THPH2 THR-387
    40. 40.
      "Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls."
      Casas J.P. , Hingorani A.D. , Bautista L.E. , Sharma P.
      Arch. Neurol.61:1652-1661(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ASSOCIATION OF VARIANT GLN-534 WITH SUSCEPTIBILITY TO ISCHSTR
    41. 41.
      "Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis."
      Steen M. , Norstroem E.A. , Tholander A.-L. , Bolton-Maggs P.H.B. , Mumford A. , McVey J.H. , Tuddenham E.G.D. , Dahlbaeck B.
      Blood103:3381-3387(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANT THPH2 THR-387
    42. 42.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT [LARGE SCALE ANALYSIS] ALA-775
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter